Rare diseases
Investigational molecules
Locations
Back to Germany1 clinical trial in Lörrach, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on advanced breast cancer treatment approaches, specifically targeting patients with HER2-negative, hormone receptor positive conditions.
Researchers are evaluating therapeutic patterns and resistance mechanisms through comprehensive spatial and temporal analysis, with particular attention to progression-free and overall survival outcomes.
Advanced studies examining the effectiveness of targeted therapies in breast cancer treatment, with a focus on understanding response patterns and treatment resistance.
The research emphasizes comprehensive analysis of treatment outcomes, particularly focusing on 12-month survival metrics and therapeutic efficacy markers.
Investigation of molecular patterns in breast cancer treatment responses, combining spatial and temporal analyses to understand disease progression.
The research aims to enhance understanding of treatment efficacy through detailed molecular and clinical response analysis in first-line therapeutic settings.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
